IRIS UniCatt

Lo Monaco, Maria Rita
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.366
AS - Asia 3.572
EU - Europa 2.842
SA - Sud America 658
AF - Africa 143
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 6
Totale 11.596
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.207
SG - Singapore 1.602
IT - Italia 746
CN - Cina 708
BR - Brasile 544
SE - Svezia 448
DE - Germania 414
VN - Vietnam 394
FR - Francia 312
HK - Hong Kong 206
GB - Regno Unito 170
IE - Irlanda 170
IN - India 110
ID - Indonesia 108
FI - Finlandia 95
JP - Giappone 91
CA - Canada 86
RU - Federazione Russa 78
PL - Polonia 70
UA - Ucraina 59
NL - Olanda 56
BE - Belgio 55
CI - Costa d'Avorio 51
BD - Bangladesh 49
KR - Corea 49
TR - Turchia 49
MX - Messico 46
IQ - Iraq 44
AT - Austria 41
AR - Argentina 39
ES - Italia 34
ZA - Sudafrica 32
SA - Arabia Saudita 23
IR - Iran 22
EC - Ecuador 21
CH - Svizzera 15
UZ - Uzbekistan 15
CZ - Repubblica Ceca 14
JO - Giordania 14
VE - Venezuela 14
PK - Pakistan 13
PH - Filippine 12
CO - Colombia 10
IL - Israele 10
KE - Kenya 10
EG - Egitto 9
GR - Grecia 9
LT - Lituania 9
AU - Australia 8
BO - Bolivia 8
MA - Marocco 8
KZ - Kazakistan 7
RO - Romania 7
AE - Emirati Arabi Uniti 6
CL - Cile 5
CR - Costa Rica 5
ET - Etiopia 5
MY - Malesia 5
PE - Perù 5
PY - Paraguay 5
TN - Tunisia 5
UY - Uruguay 5
AL - Albania 4
DZ - Algeria 4
EU - Europa 4
KW - Kuwait 4
LU - Lussemburgo 4
NI - Nicaragua 4
RS - Serbia 4
TW - Taiwan 4
AZ - Azerbaigian 3
BY - Bielorussia 3
CG - Congo 3
DK - Danimarca 3
EE - Estonia 3
HR - Croazia 3
HU - Ungheria 3
KG - Kirghizistan 3
LV - Lettonia 3
NG - Nigeria 3
NP - Nepal 3
PA - Panama 3
PT - Portogallo 3
SN - Senegal 3
TT - Trinidad e Tobago 3
AO - Angola 2
BG - Bulgaria 2
BH - Bahrain 2
CY - Cipro 2
GA - Gabon 2
GT - Guatemala 2
HN - Honduras 2
MK - Macedonia 2
OM - Oman 2
PR - Porto Rico 2
PS - Palestinian Territory 2
SR - Suriname 2
SY - Repubblica araba siriana 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BB - Barbados 1
Totale 11.572
Salva come PNG Salva come JPEG
Città #
Singapore 907
San Jose 514
Ashburn 506
Chandler 437
Rome 171
Dublin 168
New York 166
Ho Chi Minh City 139
Beijing 137
Milan 130
Los Angeles 124
Ann Arbor 119
The Dalles 111
Hefei 108
Hanoi 104
Jakarta 97
Lauterbourg 88
Tokyo 85
Dallas 83
Hong Kong 82
Chicago 81
Frankfurt am Main 72
Munich 62
São Paulo 60
Warsaw 60
Boardman 59
Abidjan 51
Helsinki 50
Cattolica 47
Moscow 46
Boston 45
Brussels 44
Princeton 43
San Mateo 43
Wilmington 42
Council Bluffs 40
Marseille 40
Houston 38
North Bergen 36
Seoul 35
Kent 34
St Louis 31
Nanjing 29
Santa Clara 29
Jacksonville 28
London 28
Nuremberg 28
Ottawa 27
Tukwila 27
Amsterdam 26
Dearborn 26
Woodbridge 24
Fairfield 23
Orem 23
Paris 23
Washington 23
Izmir 21
Redwood City 21
Turku 21
Vienna 21
Brooklyn 20
Buffalo 20
Denver 20
Johannesburg 20
Atlanta 19
Bremen 19
Da Nang 19
Rio de Janeiro 19
Haiphong 18
Baghdad 17
Lappeenranta 17
Trieste 17
Cambridge 16
Chennai 16
Seattle 16
Mexico City 15
Montreal 15
Phoenix 15
Pune 15
Düsseldorf 14
Stockholm 14
Belo Horizonte 13
Guangzhou 13
Lancaster 13
Manchester 13
Poplar 13
Amman 12
Leawood 12
Naples 12
Nürnberg 12
Shanghai 12
Tashkent 12
Toronto 12
Brno 11
City of London 11
Istanbul 11
Kish 11
Norwalk 11
Redmond 11
Tianjin 11
Totale 6.370
Salva come PNG Salva come JPEG
Nome #
Teaching neuroimages: Peroneal intraneural ganglion cyst: a rare cause of drop foot in a child. 251
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 238
Beyond the CAG triplet number: exploring potential predictors of delayed age of onset in Huntington's disease 218
The role of cognitive reserve in cognitive aging: what we can learn from Parkinson’s disease Select item 29019160 1. The role of cognitive reserve in cognitive aging: what we can learn from Parkinson's disease. 215
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 214
Malnutrition in COVID-19 survivors: prevalence and risk factors 204
Retinal capillary involvement in early post-COVID-19 patients: a healthy controlled study 202
Association of depressive symptoms with circadian blood pressure alterations in Parkinson's disease 198
Assessment of neurological manifestations in hospitalized patients with COVID-19 198
COVID-19 atypical Parsonage-Turner syndrome: a case report 197
Residual respiratory impairment after COVID-19 pneumonia 196
Residual respiratory impairment after COVID-19 pneumonia 177
An Italian Neurology Outpatient Clinic Facing SARS-CoV-2 Pandemic: Data From 2,167 Patients 175
Incidence of deep vein thrombosis among non-ICU patients hospitalized for COVID-19 despite pharmacological thromboprophylaxis 174
Prevalence of Impulsive-Compulsive Symptoms in Elderly Parkinson's Disease Patients: A Case-Control Study 171
Laterality in Parkinson's disease may predict motor and visual imagery abilities 165
Mitochondrial Signatures in Circulating Extracellular Vesicles of Older Adults with Parkinson's Disease: Results from the EXosomes in PArkiNson's Disease (EXPAND) Study 158
The impact of cognitive reserve on the effectiveness of balance rehabilitation in Parkinson's disease 156
The “development of metabolic and functional markers of dementia in older people” (ODINO) study: Rationale, design and methods 155
The New Challenge of Geriatrics: Saving Frail Older People from the SARS-COV-2 Pandemic Infection 150
Use of ACE-inhibitors and falls in patients with Parkinson's disease 148
Functional Movement Disorders during COVID-19: Psychological Distress, Affective Temperament and Emotional Dysregulation 144
An Italian Neurology Outpatient Clinic Facing SARS-CoV-2 Pandemic: Data From 2,167 Patients 143
The Geriatrician: The Frontline Specialist in the Treatment of COVID-19 Patients 143
Association of metabolic syndrome with falls in patients with Parkinson's disease 142
What about the caregiver? A journey into Parkinson’s disease following the burden tracks 140
Impact of disease duration and cardiovascular dysautonomia on hypertension in Parkinson's disease 139
Comparison of virtual reality rehabilitation and conventionalrehabilitation in Parkinson’s disease: a randomised controlledtrial 139
Functional Movement Disorders during COVID-19: Psychological Distress, Affective Temperament and Emotional Dysregulation 137
Association between frailty and ischemic heart disease: a systematic review and meta-analysis 136
Prevalence of Obsessive-Compulsive Symptoms in Elderly Parkinson Disease Patients: A Case-Control Study 134
Deprescribing in Nursing Home Residents on Polypharmacy: Incidence and Associated Factors 127
Safinamide as an adjunct therapy in older patients with Parkinson’s disease: a retrospective study 127
F057 Affective and cognitive components of theory of mind in Huntington’s disease: yoni task performance in early and mid-disease stages 126
Gender may be related to the side of the motorsyndrome and cognition in idiopathic Parkinson’sdisease 126
Prevalence of Obsessive-Compulsive Symptoms in Elderly Parkinson Disease Patients: A Case-Control Study 123
Use of proton-pump inhibitors is associated with depression: a population-based study 121
Writing errors in primary progressive aphasia 121
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 120
Theory of mind: A clue for the interpretation of functional movement disorders 120
Untangling the relationship between fat distribution, nutritional status and Parkinson's disease severity 118
Polypharmacy is a determinant of hospitalization in Parkinson's disease 117
Beyond the CAG triplet number: exploring potential predictors of delayed age of onset in Huntington's disease 115
Clinical and genetic characteristics of late-onset Huntington's disease in a large European cohort 115
Sarcopenia in Parkinson Disease: Comparison of Different Criteria and Association With Disease Severity 115
Word selection processing in Parkinson's disease: When nouns are more difficult than verbs 114
Mitochondrial dysfunction and aging: Insights from the analysis of extracellular vesicles 114
Circulating amino acid signature in older people with Parkinson's disease: A metabolic complement to the EXosomes in PArkiNson Disease (EXPAND) study 114
Should face masks be worn to contain the spread of COVID-19 in the postlockdown phase? 112
Predictive Factors for a New Positive Nasopharyngeal Swab Among Patients Recovered From COVID-19 111
Should face masks be worn to contain the spread of COVID-19 in the postlockdown phase? 110
What about the caregiver? A journey into Parkinson's disease following the burden tracks 109
Social cognition in basal ganglia pathologies: Theory of Mind in Huntington's and Parkinson's diseases 108
Gender may be related to the side of the motor syndrome and cognition in idiopathic Parkinson's disease 108
Predictive Factors for a New Positive Nasopharyngeal Swab Among Patients Recovered From COVID-19 106
Clinical and genetic characteristics of late-onset Huntington's disease in a large European cohort 106
Social cognition in Parkinson's disease and functional movement disorders 105
Comparison of virtual reality rehabilitation and conventional rehabilitation in Parkinson's disease: a randomised controlled trial 105
Association of Pisa Syndrome With Mortality in Patients With Parkinson's Disease 104
Clinical and genetic characteristics of late-onset Huntington's disease in a large European cohort 103
Efficacy and safety of long-term botulinum toxin treatment for acquired cervical dystonia: a 25-year follow-up 103
Assessment of neurological manifestations in hospitalized patients with COVID-19 102
Association of depressive symptoms with circadian blood pressure alterations in Parkinson's disease 102
Positive RT-PCR nasopharyngeal swab in patients recovered from COVID-19 disease: When does quarantine really end? 100
Gender may be related to the side of the motor syndrome and cognition in idiopathic Parkinson's disease 100
The New Challenge of Geriatrics: Saving Frail Older People from the SARS-COV-2 Pandemic Infection 99
The Geriatrician: The Frontline Specialist in the Treatment of COVID-19 Patients 94
An educational case series of Parkinson's disease during the COVID-19 pandemic 94
Incidence of deep vein thrombosis among non-ICU patients hospitalized for COVID-19 despite pharmacological thromboprophylaxis 92
Association between frailty and ischemic heart disease: a systematic review and meta-analysis 90
Correlates of cognitive impairment among patients with heart failure: results of a multicenter survey 90
Efficacy and safety of long-term botulinum toxin treatment for acquired cervical dystonia: a 25-year follow-up 89
Safinamide as an adjunct therapy in older patients with Parkinson's disease: a retrospective study 88
Balancing the risks and benefits of antipsychotic medications for symptom management in older patients with cancer 88
Emotional valence may influence memory performance for visual artworks in Parkinson’s disease 88
An educational case series of Parkinson's disease during the COVID-19 pandemic 87
Writing errors in primary progressive aphasia 87
Fucntional and clinical correlates of carotid intimal thickness in obstructive sleep apnea syndrome 87
Impaired processing of conspecifics in Parkinson's disease 86
Correction to: Beyond the CAG triplet number: exploring potential predictors of delayed age of onset in Huntington's disease 82
Positive RT-PCR nasopharyngeal swab in patients recovered from COVID-19 disease: When does quarantine really end? 81
Clinical and MRI characterization of apraxic syndrome in corticobasal degeneration: A single-case study 80
Social cognition in basal ganglia pathologies: Theory of Mind in Huntington’s and Parkinson’s diseases 79
STN-DBS does not increase the risk of sialorrhea in patients with advanced Parkinson's disease 74
Encephalopathy as neurological involvement of SARS-COV-2 infection 74
Correction to: Beyond the CAG triplet number: exploring potential predictors of delayed age of onset in Huntington’s disease (Journal of Neurology, (2022), 269, 12, (6634-6640), 10.1007/s00415-022-11297-3) 73
Use of angiotensin-converting enzyme inhibitors and variations in cognitive performance among patients with heart failure 73
The effects of cognitive impairment on mortality among hospitalized patients with heart failure 73
Theory of mind: A clue for the interpretation of functional movement disorders 72
An early feasibility study for neurological devices: The ARCTRAN study 71
Of microbes and minds: A narrative review on the second brain aging 67
Subacute onset dystonia in a woman affected by Parkinson's disease following SARS-COV-2 infection 65
Subacute onset dystonia in a woman affected by Parkinson's disease following SARS-COV-2 infection 59
The “development of metabolic and functional markers of dementia in older people” (ODINO) study: Rationale, design and methods 58
Mitochondrial Signatures in Circulating Extracellular Vesicles of Older Adults with Parkinson's Disease: Results from the EXosomes in PArkiNson's Disease (EXPAND) Study 55
Neuropsychological measures of post-COVID-19 cognitive status 50
Mitochondrial-Derived Vesicles as Candidate Biomarkers in Parkinson's Disease: Rationale, Design and Methods of the EXosomes in PArkiNson Disease (EXPAND) Study 50
An early feasibility study for neurological devices: The ARCTRAN study 44
Coronary risk factors in the elderly: Their interactions and treatment 43
Mitochondrial-Derived Vesicles as Candidate Biomarkers in Parkinson's Disease: Rationale, Design and Methods of the EXosomes in PArkiNson Disease (EXPAND) Study 35
Totale 11.801
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.469
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.469
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022540 38 21 13 44 31 18 15 81 15 43 107 114
2022/20231.586 160 167 85 215 73 165 108 103 332 87 76 15
2023/20241.182 37 245 74 83 75 198 76 63 16 73 101 141
2024/20252.180 50 51 168 90 169 101 90 76 302 218 483 382
2025/20265.276 727 203 384 613 828 267 954 295 310 413 147 135
2026/202740 40 0 0 0 0 0 0 0 0 0 0 0
Totale 11.801